Form D · Biotechnology
Neurofold Therapeutics Inc.
Greenwood Village, CO · CIK 0002145237
Offering snapshot reported Jul 14, 2026 · SEC filing
- Reported sold
- $6.5M Offering amount: $6.5M
- Investors reported
- 18 Form D · investor count
- Minimum accepted
- $10K Reported outside-investor minimum
- First sale
- Jun 25, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jul 14, 2026 | Initial | $6,499,987 | No comparison | 18 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-590646
SAFE (Simple Agreement for Future Equity)
Source: Form D, filed Jul 14, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No matching detailed fund disclosure was found in the latest imported ADV filings. This does not establish that the issuer has no adviser.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Gurdane Bhutani | Director |
| Rajeev Kumar | Director, Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5500 S. Marigold Court
Greenwood Village, CO, 80121
Phone: 303-564-8817
Greenwood Village, CO, 80121
Phone: 303-564-8817